Russell Investments Group Ltd. increased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 17.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 259,916 shares of the company’s stock after buying an additional 38,267 shares during the period. Russell Investments Group Ltd.’s holdings in Acadia Healthcare were worth $12,836,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in ACHC. Emerald Mutual Fund Advisers Trust bought a new stake in shares of Acadia Healthcare during the first quarter worth approximately $210,000. Paloma Partners Management Co bought a new stake in shares of Acadia Healthcare during the first quarter worth approximately $217,000. M&T Bank Corp bought a new stake in shares of Acadia Healthcare during the first quarter worth approximately $230,000. Teacher Retirement System of Texas bought a new stake in shares of Acadia Healthcare during the first quarter worth approximately $258,000. Finally, Benjamin F. Edwards & Company Inc. increased its stake in shares of Acadia Healthcare by 224.2% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 6,290 shares of the company’s stock worth $274,000 after buying an additional 4,350 shares during the period.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) traded up 2.77% during mid-day trading on Friday, hitting $52.38. The stock had a trading volume of 1,219,461 shares. The company has a market cap of $4.60 billion, a P/E ratio of 575.60 and a beta of 1.15. The company has a 50-day moving average price of $50.30 and a 200 day moving average price of $44.67. Acadia Healthcare Company, Inc. has a 1-year low of $32.54 and a 1-year high of $54.73.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The company had revenue of $715.90 million during the quarter, compared to analyst estimates of $717.38 million. During the same quarter in the previous year, the business earned $0.73 EPS. The firm’s revenue was down 5.4% on a year-over-year basis. Equities research analysts forecast that Acadia Healthcare Company, Inc. will post $2.45 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This story was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The legal version of this story can be accessed at https://www.watchlistnews.com/russell-investments-group-ltd-buys-38267-shares-of-acadia-healthcare-company-inc-achc/1479468.html.

A number of brokerages have recently commented on ACHC. Craig Hallum reiterated a “buy” rating and set a $65.00 price objective (up previously from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. UBS AG reiterated a “positive” rating and set a $60.00 price objective (up previously from $54.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Zacks Investment Research downgraded Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, August 1st. BidaskClub downgraded Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Finally, Mizuho increased their price objective on Acadia Healthcare from $57.00 to $60.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Five equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $59.21.

In other news, EVP Christopher L. Howard sold 16,762 shares of the business’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $52.47, for a total value of $879,502.14. Following the completion of the transaction, the executive vice president now owns 200,999 shares of the company’s stock, valued at approximately $10,546,417.53. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Reeve B. Waud sold 50,000 shares of the business’s stock in a transaction on Friday, June 9th. The shares were sold at an average price of $45.09, for a total transaction of $2,254,500.00. The disclosure for this sale can be found here. Insiders sold a total of 2,136,347 shares of company stock valued at $105,383,249 in the last three months. 11.10% of the stock is owned by company insiders.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.